Concierge gives you timely BUY and SELL alerts on ASX-listed stocks
ASX Life Sciences stocks discussed by Stuart Roberts as interest rates peak
What are the Best ASX Stocks to invest in right now?
Check our buy/sell tips on the top Stocks in ASX
When looking at ASX Life Sciences stocks, Stuart points out Neuren Pharmaceuticals (ASX:NEU), saying the company received FDA approval in March for trofinetide and that they are on the verge of developing a new drug. Stuart sees a promising future for the company, foreseeing its potential to become a major pharma firm once investors realise its potential.
He also his view on Botanix Pharmaceuticals (ASX:BOT), another company worth watching due to its potential FDA approval for a drug treating primary axillary hyperhidrosis, a condition affecting 10% of the population. He presents the numerous companies maturing in the life sciences sector, moving beyond approval into the commercialisation stage.
Stuart recommends seeking expert guidance, accessing research, diversifying risk and ensuring only a fraction of your portfolio is exposed to these potentially volatile ASX Life Sciences stocks.
Stocks Down Under Concierge is here to help you pick winning stocks!
The team at Stocks Down Under have been in the markets since the mid-90s and we have gone through many ups and downs. We have written about every sector, including ASX Life Sciences stocks!
Our Concierge BUY and SELL service picks the best stocks on ASX. We won’t just tell you what to buy – we give you a buy range, price target and stop loss level in order to maximise total returns. And we will only recommend very high conviction stocks where substantial due diligence has been conducted.
Our performance is well ahead of the ASX200 and All Ords.
You can try out Concierge … for FREE.
There’s no credit card needed – the trial expires automatically.
The Rule of 72: Why it might be useful to consider when investing in Stocks Investing in stocks can be…
How to tell which stocks to buy? Investing in markets such as the ASX can be an exciting and profitable venture,…